Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/advance-article-pdf/doi/10.1093/annonc/mdz232/30076098/mdz232.pdf
Reference32 articles.
1. Prevalence of off-label use of oral oncolytics at a community cancer center;Kalis;J Oncol Pract,2015
2. Prevalence of off-label use and spending in 2010 among patent-protected chemotherapies in a population-based cohort of medical oncologists;Conti;J Clin Oncol,2013
3. Off-label use of oncology drugs: too much, too little, or just right?;Burstein;J Natl Compr Canc Netw,2013
4. Frequency and level of evidence used in recommendations by the National Comprehensive Cancer Network guidelines beyond approvals of the US Food and Drug Administration: retrospective observational study;Wagner;BMJ,2018
5. Randomized phase 2 trial of two different doses of ixazomib in patients with relapsed multiple myeloma not refractory to bortezomib;Kumar;Blood,2015
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Use of suboptimal control arms in randomized clinical trials of investigational cancer drugs in China, 2016–2021: An observational study;PLOS Medicine;2023-12-12
2. Efficacy of Off-Label Use of Anticancer Drugs in Oncology;Creative surgery and oncology;2023-06-30
3. Systematic analysis of off-label and off-guideline cancer therapy usage in a real-world cohort of 153,122 U.S. patients;2023-01-18
4. Characterization of the Early Years of Bevacizumab Use for First-Line Treatment of Ovarian Cancer in the United States;JCO Oncology Practice;2021-11
5. Assessment of Drugs Approved by Public Knowledge‐Based Applications ( Kouchi‐shinsei ) During the Last Two Decades in Japan;Clinical Pharmacology & Therapeutics;2021-07-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3